HOOKIPA Pharma Inc.

OTCPK:HOOK Stock Report

Market Cap: US$11.5m

HOOKIPA Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:HOOK Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
19 Aug 25SellUS$20,684Malte PetersIndividual25,172US$0.82
22 Jul 25SellUS$12,520Mary CoelhoIndividual13,609US$0.92
22 Jul 25SellUS$26,842Malte PetersIndividual29,176US$0.92
06 Feb 25SellUS$190FMR LLCCompany100US$1.90
04 Feb 25SellUS$688FMR LLCCompany366US$1.88
30 Jan 25SellUS$4,228Fidelity International LtdCompany2,114US$2.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of HOOK?
Owner TypeNumber of SharesOwnership Percentage
Public Companies00%
Individual Insiders36,3160.283%
Institutions1,668,19813%
General Public11,110,02686.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 19 shareholders own 13.3% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
3.89%
Knoll Capital Management
498,625US$446.3k0%0.24%
2.71%
JBF Capital, Inc.
347,000US$310.6k0%0.04%
2.45%
Sofinnova Partners SAS
314,259US$281.3k0%0.02%
2.16%
Baker Bros. Advisors LP
276,951US$247.9k-74.6%no data
1.36%
Fidelity International Ltd
174,884US$156.5k0%no data
0.22%
Acadian Asset Management LLC
28,020US$25.1k-49.7%no data
0.17%
Mary Coelho
21,329US$19.1k0%no data
0.14%
XTX Markets Limited
18,056US$16.2k0%no data
0.069%
Pacific Life Fund Advisors LLC
8,859US$7.9k0%no data
0.056%
Joern Aldag
7,195US$6.4k0%no data
0.034%
Reinhard Kandera
4,308US$3.9k0%no data
0.013%
Christine Baker
1,616US$1.4k0%no data
0.0071%
Jan G.J. de Winkel
915US$818.90%no data
0.0053%
Constellation Investments, Inc.
679US$607.90%no data
0.004%
Osaic Wealth, Inc.
513US$458.82.6%no data
0.0039%
Julie O'Neill
496US$443.90%no data
0.0036%
David Kaufman
457US$409.40%no data
0.0027%
Simplex Trading, LLC
341US$305.10%no data
0.00009%
Guggenheim Partners, LLC
11US$10.30%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/26 18:51
End of Day Share Price 2025/12/24 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

HOOKIPA Pharma Inc. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Alec StranahanBofA Global Research
Swayampakula RamakanthH.C. Wainwright & Co.
Debjit ChattopadhyayH.C. Wainwright & Co.